Compare CRNC & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRNC | OFIX |
|---|---|---|
| Founded | 2020 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.9M | 473.3M |
| IPO Year | 2019 | 1998 |
| Metric | CRNC | OFIX |
|---|---|---|
| Price | $10.31 | $9.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | $10.25 | ★ $17.25 |
| AVG Volume (30 Days) | ★ 1.0M | 407.9K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 96.95 | 29.39 |
| EPS | ★ N/A | N/A |
| Revenue | $251,781,000.00 | ★ $822,312,000.00 |
| Revenue This Year | $27.18 | $6.13 |
| Revenue Next Year | N/A | $6.22 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $5.85 | $8.85 |
| 52 Week High | $13.74 | $16.99 |
| Indicator | CRNC | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 48.41 | 45.28 |
| Support Level | $9.18 | $9.13 |
| Resistance Level | $11.49 | $9.90 |
| Average True Range (ATR) | 0.80 | 0.44 |
| MACD | -0.16 | 0.09 |
| Stochastic Oscillator | 43.41 | 49.66 |
Cerence Inc is a United States-based software company. It is involved in developing mobility-based solutions for drivers and their cars. The customers include all automobile original equipment manufacturers, or OEMs, or their tier 1 suppliers. The company's revenue is generated by selling software licenses and cloud-connected services. Geographically, it derives a majority of its revenue from the United States and also has a presence in Other Americas; Germany; Other Europe, the Middle East, Africa; Japan, and Other Asia-Pacific.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.